MaxCyte, Inc. (MXCT)

MaxCyte Revenue

MaxCyte had revenue of $7.27M in the quarter ending June 30, 2026, a decrease of -14.53%. This brings the company's total for the last twelve months to $31.05M, down -13.15% year-over-year. In the year 2025, MaxCyte had annual revenue of $33.03M, down -14.50%. That makes MaxCyte the 31,149th largest company in the world by revenue and 4,111th in the United States.

• Revenue (ttm): $31.05M
• Revenue Growth: -13.15%
• P/S Ratio: 5.28
• Revenue / Employee: $341,220
• Employees: 91
• Market Cap: 164.10M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 21.08M 63.8%
• Outside The United States 11.95M 36.2%

Fiscal year ended Dec 31, 2025 See the full MaxCyte breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	33.03M	-5.60M	-14.50%
Dec 31, 2024	38.63M	-2.66M	-6.44%
Dec 31, 2023	41.29M	-2.97M	-6.72%
Dec 31, 2022	44.26M	10.37M	30.59%
Dec 31, 2021	33.89M	7.73M	29.52%
Dec 31, 2020	26.17M	4.55M	21.04%
Dec 31, 2019	21.62M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error